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 Abstract 
 
The aim of this study was to examine whether a mobile phone has any 
measurable effects on the average erythrocyte aggregation (AEA) in whole 
undried peripheral blood, and whether a mobileFloww device has any measurable 
effects on the AEA size in such whole undried peripheral blood. The study was a 
placebo-controlled double-blind randomised one. The images made with the 
dark-field microscope were counted in channels. Aggregation was defined by red 
blood cells that overlapped. Each aggregation was accounted for separately 
within each image. Cell deformation was defined as cells having a non-round 
shape that was visually distinctly different from a round shape. The result showed 
that the mean AEA of the three groups “mobile”, “placebo” and “floww” was 
51.7, 18.5 and 27.8 respectively. The median AEA for these three groups was 53.2, 
14.0 and 4.1, respectively. No statistically significant differences were 
established meaning that we could not demonstrate any effect of mobile phone 
radiation on the AEA of peripheral blood, and, thus, as a consequence we could 
not establish any possible effect of the “mobileFloww” device. 
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Introduction 
An increasing number of people, governments and institutions, including the World Health 
Organization and the Council of Europe, show concern about the health effects of electromagnetic 
radiation. Scientific studies show a connection between artificial electromagnetic fields and stress 
and fatigue. Yet wireless communication has become indispensable. More and more electronic 
wireless communication devices are in use throughout the world, with more breadth of usage across 
locations and ages with new networks, and the ability to be online anywhere and at any time. The 
adoption and use growth percentage of wireless networks of several types have increased 
significantly in the last 10 years. All these wireless networks generate different forms of non-
ionising, electromagnetic radiation of various frequencies, modulations, pulsations and strengths. 
The age of the users has spread to the youngest and oldest in the last years. Therefore it becomes 
more and more important to find ways to utilize these forms of radiation in a responsible way, thus 
trying to protect the users. This is the aim of Floww Health Technology. 
What is known 
The earliest research regarding these electromagnetic fields and their potential effects dates back to 
1970 and before, with a definite increase in the volume of studies in this field in the last years. The 
investigation methods and results are diverse. This is understandable because there is no single 
unequivocally proven mechanism yet for how the radiation from these networks could influence a 
human being, animals, plants or bacteria. This is highlighted further by the absence of replications of 
studies completed before.  
The results of the known studies so far are diverse. Most studies focus on the short-term effect. 
Recently, a theory has been proposed about polarisation of molecules that aims to explain some of 
the chemical chain events in human beings occurring as a result of such artificial electromagnetic 
radiation, bringing an explanation of a potential mechanism closer. 
Area where information is missing  
Studies mainly focus on the effects of this electromagnetic radiation, or absence of effects, to 
determine whether there is a potential danger for human beings. That there are potential negative 
effects is clear, but studies that focus on potential solutions other than shielding are few and far 
between. Studies into potential solutions other than shielding for people who experience effects, 
with thorough methodology, blinding and randomisation are even more scarce.   
Aims of this study 
The aim of this study was to examine whether a mobile phone has any measurable effects on the 
average erythrocyte aggregation (AEA) in whole undried peripheral blood, and whether a 
mobileFloww device has any measurable effects on the AEA size in such whole undried peripheral 
blood. Since the effects of wireless electromagnetic radiation can potentially be subtle and/or 
individually unpredictable, an influence of the psychological state of a participant cannot be 
excluded upfront. Hence another aim of this study is to determine the general ‘psychological state’ 
of the participants with questionnaires before and after interventions. 
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Hypotheses 
The first hypothesis was: An active mobile phone with a “placebo mobileFloww” device will lead to a 
significant increase of AEA in undried blood. 
The second hypothesis was: An active mobile phone with an “active mobileFloww” device will 
restore the AEA in undried blood back to normal levels. 
The third hypothesis was: The psychological state of a participant can alter their AEA in undried 
peripheral blood. 
Design 
Study description 
The study was a placebo-controlled double-blind randomised one. In view of the actual 
circumstances with participants, investigators, observers and device preparation blinded, it was a 
triple-blinded study. It was carried out at the offices of Floww International in Nuland, The 
Netherlands, in a wing of the building that was closed to others during the study. The study was 
performed with 18 healthy participants each receiving two interventions, with the aim of providing a 
reasonable pilot sample size based on the outcome of earlier experiments. A short questionnaire 
was used before and after interventions to sample the general ‘psychological state’ of the 
participants and to provide a way to assess the level of bias their psychological state may have 
contributed to the outcome of the study. 
Interventions 
The interventions that were compared are: 
1. a mobile phone that was turned completely off with a dummy mobileFloww device attached 
to the phone (‘placebo’); 
2. a mobile phone with active phone call but without active user actions with a dummy 
mobileFloww device attached to the phone (‘mobile’); 
3. a mobile phone with active phone call but without active user actions with a working 
mobileFloww device attached to the phone (‘floww’). 
Study population 
To avoid bias in selection, recruitment has taken place through 3 adverts in  two regional 
newspapers that were distributed door-to-door in the area of Hertogenbosch, close to the Floww 
company premises. Twenty participants were entered that met the inclusion/exclusion criteria on a 
first-come first-serve basis. Ten reserve participants that met the inclusion/exclusion criteria were 
entered on a first-come first-serve basis to fill in in case a participant was unexpectedly not present. 
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Methods and Materials 
Delivery of interventions 
The interventions were delivered to the participant in a black cotton glove with elastic band on the 
inside to hold the mobile phone in place. The interventions were prepared by a separate 
independent blinded person who had no contact with the investigators during the study. After 
preparation, the glove was carried to the research room and left outside the door. The investigators 
picked up the glove from outside the door for use by a participant. The participant put his/her hand 
in the glove on top of the test object. After 15 minutes, the participant was informed that they could 
withdraw their hand from the glove. The glove with the intervention device was then taken away 
from the participant and placed outside the study room door without opening the glove. 
Only strict necessary communication was allowed between the participant and the 
investigators/observers. No subject of any kind was discussed during the study other than 
procedural questions and/or directions that were needed during the tests.  
Blinding/randomisation 
The participants were given a number after they had signed and sent their consent forms. The 
notary assigned the participant’s number to the interventions randomly with a 1:2 ratio between the 
placebo and the other intervention groups. The participant numbers were written on envelopes, 
with the interventions a participant was to receive written on a piece of paper and inserted into the 
envelope with that participant’s number. The envelope was then sealed. All envelopes were sealed 
in a larger envelope by the notary. The envelope for any particular participant was only opened just 
before the start of that participant’s test by the person preparing the interventions, thus ensuring 
that every step remained completely blinded. The intervention devices were stored after each test 
day with the independent person that prepared the interventions to keep the blinding intact.  
Only the notary had the key to the blind code, all others were blinded to which intervention code 
was which. Furthermore, only the person preparing the interventions knew which participant 
numbers received which intervention within approximately ten minutes before the start of each 
participant’s testing. The investigators, the support staff and the observers were blinded as to what 
interventions which participant received. The personal details of the participants were kept in a 
secure position during the study. The investigators, the observers and the intervention preparation 
person had no part in the selection process and were blinded to the identity of the participants 
during the study.  
Randomisation of images was done by using the center of a blood drop as reference from which to 
generate four randomised locations for the subsample acquisition. 
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Image analysis and counting of red blood cells (RBCs) 
The images made with the dark-field microscope (DFM) were counted in channels. Aggregation was 
defined by red blood cells that overlapped. Each aggregation was accounted for separately within 
each image. Cell deformation was defined as cells having a non-round shape that was visually 
distinctly different from a round shape. A visual analogue scale (VAS) was done by grouping the 
images into categories and translating these categories into a scale from 0 to 100. Cell form 
deformations were counted. All analysis, counting and scoring was done by the two investigators 
separately and before any blinding was broken. 
Dark Field Microscope (DFM) 
The DFM used was a Hund-Wetzlar H 600 LL HP/NP 50/100, with 100x oil-immersed objective.  
Research location 
The location used was a wing of the Floww company building that was closed to other people during 
the study, with a separate side door being used for the study participants and the main entrance 
being locked. The setup was such that every participant was stationed in a separate room, and that 
they were guided through the hallway by research staff to ensure that there was no interaction 
between participants before or after testing. The intervention devices were prepared in a separate 
room as well, and were carried to and from the research room separately by the same person that 
guided the participants.  
During the investigations, the investigators were not allowed to leave the study location. The 
observers were free to walk between rooms and assess that no interaction took place outside of the 
prescribed procedures for the study.  
Protocol breach 
On the evening before the start of the study, the primary investigator learned that 4 participants 
with indirect ties to company personnel had been entered into the study inadvertently. The 
participants involved were taken off the list, and both independent observers were informed of the 
breach of protocol and the rectification measures taken. Due to the exclusion, reserve participants 
were used to fill 2 participant slots. The other slots could not be filled by reserve participants, which 
lowered the number of participants from 20 to 18.  
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Results 
The results below are given for the entire groups ‘mobile’, ‘placebo’ and ‘floww’ across intervention 
moments, and are given as means and medians with a confidence interval (CI) of 95% as error bars.  
Three types of results are reported below: the mean and median Average Erythrocyte Aggregation 
(AEA),  the mean and median Visual Analogue Scale (VAS),  and the mean and median number of cell 
deformations. 
Mean and median  
To exclude any individual influences, the results were averaged over participants for each 
investigator performing the analysis. These final averages for each observer were then averaged as 
well to obtain the mean values. 
Besides the mean, the median was also chosen as a value to report on. The median (the middle 
value of all mean values) is of interest because it shows whether or not the collection of mean values 
are normally distributed or not. When the median deviates a lot from the mean, it means that the 
collection of values are not normally distributed but that the population is skewed to one side. 
When the median is lower than the mean, this means that values below the mean are present more 
often than the values that are higher than the mean. 
Average Erythrocyte Aggregation (AEA) 
The mean and median Average Erythrocyte Aggregation (AEA) for the groups were: 
 Mean Median 
mobile 51.7 53.2 
placebo 18.5 14.0 
floww 27.8 4.1 
 
The results for the mean and median Average Erythrocyte Aggregation (AEA) are detailed below in 
graphical form in Figure 1 and 2.  
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Figure 1: Mean average erythrocyte aggregation for all three intervention groups  
Figure 2 indicates that the mean aggregation size in the ‘mobile’ group was larger than in the other 
groups, that the mean aggregation size in the ‘placebo’ group was lowest, and that the mean 
aggregation size in the ‘floww’ group was in between the other two groups, being approximately 
50% lower than the ‘mobile’ group and 35% higher than the ‘placebo’ group. 
 
Figure 2: Median average erythrocyte aggregation for all three intervention groups  
Figure 2 indicates that the median aggregation size in the ‘mobile’ group was highest, that the 
median aggregation size in the ‘placebo’ group was in between the other two groups and that the 
‘floww’ group median aggregation was lowest. The values for the ‘placebo’ and ‘floww’ groups were 
approximately 75% and 90% lower than the median value for the ‘mobile’ group, respectively. 
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Visual Analogue Scale 
A Visual Analogue Scale (VAS) was given to each image processed as an alternative way to score the 
results. The VAS was averaged out for each test and for each investigator performing the analysis. To 
obtain a VAS, each image was given a score between 0 and 100, where 0 means a completely 
unaggregated image and 100 means a completely aggregated image. 
 Mean Median 
mobile 39.2 43.1 
placebo 33.9 37.2 
floww 36.9 28.9 
 
The results for the mean and median VAS are detailed below. 
 
Figure 3: Mean visual analogue scale for all three intervention groups  
Figure 3 shows that the mean VAS for all groups did not differ from each other, with all groups being 
within a bandwidth of approximately 3 points or 15% of each other.  
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Figure 4: Median visual analogue scale for all three intervention groups  
Figure 4 shows that the median value for the three groups indicates a somewhat bigger difference 
than the mean value. The median for the ‘mobile’ group was highest, followed by the ‘placebo’ 
group with the ‘floww’ group median value being the lowest. The ‘placebo’ and ‘floww’ median was 
approximately 15% and 35% lower than the ‘mobile’ group median value respectively. 
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Cell deformations 
The number of cell deformations for each image were processed as an alternative way to score the 
results. A deformation was defined as a deviation from the normal round shape of an erythrocyte. 
Deviations like dents were counted and averaged out to obtain the values presented below. 
 Mean Median 
mobile 12.7 9.5 
placebo 28.8 34.5 
floww 13.4 14.5 
 
The results for the mean and median cell deformations are detailed below. 
 
Figure 5: Mean number of deformed cells for all three intervention groups  
Figure 5 shows that the average number of cell deformations were largest in the ‘placebo’ group, 
followed by almost identical values for the groups ‘mobile’ and ‘floww’. The values for the ‘mobile’ 
and the ‘floww’ groups were approximately 55%  lower than for the ‘placebo’ group.  
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Figure 6: Median number of deformed cells for all three intervention groups  
Figure 6 shows that the median deformation was highest for the ‘placebo’ group, followed by the 
‘floww’ group with the ‘mobile’ group showing the lowest value. The values for the ‘mobile’ and 
‘floww’ groups were approximately 75% and 60% lower than the value from the ‘placebo’ group 
respectively. 
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Statistical Analysis 
The result show that the mean AEA of the three groups “mobile”, “placebo” and “floww” was 51.7, 
18.5 and 27.8 respectively. The median AEA for these three groups was 53.2, 14.0 and 4.1, 
respectively. The data was analysed by Elisabeth Berg at the LIME/MedStat unit of the Karolinska 
Institute using a Statistical Analysis System (SAS) software package employing a mixed procedure for 
statistical differences between the intervention moments and for the differences between the 
interventions ‘mobile’, ‘placebo’, and ‘floww’. Differences in mean and median values were 
observed for two of the three scoring systems, but none were statistically significant, meaning that 
we could not demonstrate any effect of mobile phone radiation on the AEA of peripheral blood, and, 
thus, as a consequence we could not establish any possible effect of the “mobileFloww” device. 
The results from the psychological questionnaires were not statistically analysed, since no significant 
results from the other data meant that no conclusions about the psychological state were possible. 
Discussion 
This study set out to investigate the effects of a mobile phone with and without a “mobileFloww” 
device on the average erythrocyte aggregation (AEA) in whole undried peripheral blood. The results 
show that difference trends in means and medians were present, but they were not statistically 
significant. 
There are several possible reasons why the results in this study are not statistically significant, while 
the uncontrolled experiments beforehand did show differences. At this point, these reasons are 
purely speculative, since a full analysis and re-testing of i.a. the measurement instrument/method 
remains to be done. A non-exhaustive list of possible reasons is given below: 
- the number of participants in this pilot is low; 
- due to the setup, the statistical power was low, where a cross-over design would have been 
more favourable; 
- there may have been variables present that are unknown at this time; 
- there are studies that denote physical differences between people suffering from 
electrohypersensitivity (EHS) and people not suffering from EHS, while the participant group 
chosen in this study due to the selection criteria may have responded differently from 
people suffering from EHS; 
- the measuring method may not have been sensitive enough; 
- the outcome may also be correct, thus demonstrating that mobile phone radiation does not 
increase the AEA of peripheral blood in the current setup, potentially leaving us with an 
impossible task to prove any effect  of the “mobileFloww” device through this measurement 
method. 
This study is just one of the steps of investigation into the Floww devices. Since the study does not 
show significant differences, all potential next steps need to be assessed before a follow-up study is 
done, including a re-assessment of the measurement method.  
 
13 
 
Invitation 
At this point, we would like to acknowledge the outstanding contributions of everyone involved so 
far, and extend a heartfelt invitation to all scientists who feel they have something to contribute to 
provide Floww with feedback, comments and possible avenues of investigation. We are on a mission 
to further the use of weak electromagnetic radiation for the absolute well-being of people, while still 
retaining and combining an open mind with rigorous research methodology. For these reasons, we 
are more than happy to share our raw data with any serious, yet critical scientist, for together we 
know more than apart. You can contact us at paul.mak@floww.com for any inquiries. 
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Appendix 
Intervention delivery and devices 
     
Figure 7, 8, 9: Glove used for intervention (100% cotton, zipper and elastic band are adjustments for the 
study) 
 
Figure 10: Intervention devices wrapped in paper to ensure identical touch sensation 
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Research location  
 
                                            
Figure 11, 12: Hallway in two parts: with research room door (left picture, right door), and hallway from 
research room to the other rooms ending with the side door used for entry. 
                                           
Figure 13, 14: View from hallway into research room 
NB The pictures here are meant to show the setup during the study. The DFM, computers and observer chairs 
in the study were different from the ones depicted here. Their location, however, is correct.  
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Figures 15, 16, 17: Research room setup 
     
Figures 18, 19, 20: Research room setup (cont.) 
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Path to side door 
 
   
Figure 21: Entry onto the company grounds Figure 22: Next to tree 
   
Figure 23: Beside building    Figure 24: Side door 
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Example images for different levels of aggregation 
  
Average aggregation level: 52   Average aggregation level: 27 
  
Average aggregation level: 18   Average aggregation level: 4 
 
 
